What is KINRIX?
Who should be given KINRIX?
Who should not be given KINRIX?
What are the possible side effects of KINRIX?
How is KINRIX given?
What are the ingredients in KINRIX?
KINRIX is a vaccine given by injection (shot) to eligible children 4 through 6 years of age to prevent four serious diseases: diphtheria, tetanus (lockjaw), pertussis (whooping cough), and poliomyelitis (polio). The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. The vaccine cannot cause any of these diseases.
Vaccination is the best way to protect against these diseases. As with any
vaccine, KINRIX may not protect all individuals receiving the vaccine
(especially those with immune system disorders), and is not recommended
for treatment of these diseases.
Back to Top
KINRIX is used in children 4 through 6 years of age (prior to the seventh
birthday) as the fifth dose in the diphtheria, tetanus, and pertussis (DTaP)
vaccine series and the fourth dose in the poliomyelitis (IPV) vaccine
series. Whether your child should be given KINRIX will depend on your
child's medical history, including their vaccination history. Your doctor
will determine whether KINRIX is right for your child.
Back to Top
Before your child receives KINRIX, you must tell your doctor or other healthcare professional if your child:
Also, tell your doctor if your child:
As with any vaccine, there may be some side effects, but it is possible that your child will have no side effects.
The most common side effects of KINRIX are:
These side effects usually are mild and generally go away on their own. If these side effects or any other side effects continue or become severe, tell your child's doctor. These are not all the possible side effects of KINRIX. You can ask your child's healthcare provider for a more complete list.
As with any vaccine, there is a risk of allergic reactions. Signs of a severe
allergic reaction may include hives, difficulty breathing, and swelling of
the throat. If any of these events occur, you should seek medical treatment
immediately. Such rare reactions usually occur before leaving the
doctor's office.
Back to Top
KINRIX is given as a single injection (shot) into a muscle in your child's arm.
Back to Top
KINRIX contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria and inactivated polio viruses. The vaccine also contains sodium chloride and aluminum salts. Low levels of formaldehyde, polysorbate 80, neomycin sulfate (antibiotic) and polymyxin B (antibiotic) are present.
KINRIX contains no preservatives.
Back to Top
KINRIX is indicated for the fifth DTaP and fourth dose IPV in 4 to 6 year olds whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX.
In clinical studies, common adverse events were injection-site reactions (pain, redness, swelling, or increase in arm circumference), drowsiness, fever, and loss of appetite. Previous hypersensitivity to any component of KINRIX, including neomycin and polymyxin B, is a contraindication. Encephalopathy within 7 days of administration of a previous pertussis-containing vaccine or a progressive neurologic disorder is a contraindication. The decision to give KINRIX should be based on potential benefits and risks, if Guillain-Barré syndrome has occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid, or if adverse events have occurred in temporal relation to receipt of a pertussis-containing vaccine. The needleless, prefilled syringes contain dry natural latex rubber and may cause allergic reactions. For children at higher risk for seizures, an antipyretic may be administered at the time of vaccination. Vaccination with KINRIX may not protect all individuals who received the vaccine.
Download the Complete Prescribing Information for KINRIX
Download Patient Information for KINRIX
Infanrix® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)
Pediarix® [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
KINRIX is a trademark of GlaxoSmithKline.
Manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium
Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709